PortfoliosLab logoPortfoliosLab logo
IBB vs. SCHY
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

IBB vs. SCHY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in iShares Nasdaq Biotechnology ETF (IBB) and Schwab International Dividend Equity ETF (SCHY). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, IBB achieves a -1.02% return, which is significantly lower than SCHY's 7.47% return.


IBB

1D
-0.90%
1M
-1.78%
YTD
-1.02%
6M
-1.60%
1Y
31.79%
3Y*
9.31%
5Y*
1.05%
10Y*
6.75%

SCHY

1D
0.09%
1M
-0.99%
YTD
7.47%
6M
10.12%
1Y
21.14%
3Y*
14.84%
5Y*
7.76%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

IBB vs. SCHY - Yearly Performance Comparison


2026 (YTD)20252024202320222021
IBB
iShares Nasdaq Biotechnology ETF
-1.02%27.98%-2.41%3.76%-13.69%-1.37%
SCHY
Schwab International Dividend Equity ETF
7.47%33.98%-1.79%14.27%-9.43%4.08%

Correlation

The correlation between IBB and SCHY is 0.53, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.53

Correlation (3Y)
Calculated over the trailing 3-year period

0.52

Correlation (5Y)
Calculated over the trailing 5-year period

0.51

Correlation (All Time)
Calculated using the full available price history since Apr 30, 2021

0.51

The correlation between IBB and SCHY has been stable across timeframes, ranging from 0.51 to 0.53 - a consistent structural relationship.

IBB vs. SCHY - Sectors Allocation Comparison


Sectors
IBB
SCHY

Healthcare

100.0%
4.0%

Basic Materials

-

5.7%

Communication Services

-

15.8%

Consumer Cyclical

-

7.9%

Consumer Defensive

-

14.8%

Energy

-

10.3%

Financial Services

-

15.8%

Industrials

-

13.8%

Real Estate

-

0.9%

Technology

-

3.8%

Utilities

-

7.4%

Healthcare

IBB
100.0%
SCHY
4.0%

Basic Materials

IBB

-

SCHY
5.7%

Communication Services

IBB

-

SCHY
15.8%

Consumer Cyclical

IBB

-

SCHY
7.9%

Consumer Defensive

IBB

-

SCHY
14.8%

Energy

IBB

-

SCHY
10.3%

Financial Services

IBB

-

SCHY
15.8%

Industrials

IBB

-

SCHY
13.8%

Real Estate

IBB

-

SCHY
0.9%

Technology

IBB

-

SCHY
3.8%

Utilities

IBB

-

SCHY
7.4%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

IBB vs. SCHY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IBB
IBB Risk / Return Rank: 5757
Overall Rank
IBB Sharpe Ratio Rank: 5151
Sharpe Ratio Rank
IBB Sortino Ratio Rank: 5353
Sortino Ratio Rank
IBB Omega Ratio Rank: 4747
Omega Ratio Rank
IBB Calmar Ratio Rank: 7272
Calmar Ratio Rank
IBB Martin Ratio Rank: 6363
Martin Ratio Rank

SCHY
SCHY Risk / Return Rank: 5454
Overall Rank
SCHY Sharpe Ratio Rank: 5959
Sharpe Ratio Rank
SCHY Sortino Ratio Rank: 5757
Sortino Ratio Rank
SCHY Omega Ratio Rank: 5656
Omega Ratio Rank
SCHY Calmar Ratio Rank: 5252
Calmar Ratio Rank
SCHY Martin Ratio Rank: 4848
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IBB vs. SCHY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares Nasdaq Biotechnology ETF (IBB) and Schwab International Dividend Equity ETF (SCHY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


IBBSCHYDifference
Sharpe ratioReturn per unit of total volatility

-0.19

Sortino ratioReturn per unit of downside risk

-0.13

Omega ratioGain probability vs. loss probability

1.27

1.31

-0.04

Calmar ratioReturn relative to maximum drawdown

3.32

2.33

+0.98

Martin ratioReturn relative to average drawdown

10.36

7.31

+3.06

IBB vs. SCHY - Sharpe Ratio Comparison

The current IBB Sharpe Ratio is 1.59, which is comparable to the SCHY Sharpe Ratio of 1.78. The chart below compares the historical Sharpe Ratios of IBB and SCHY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


IBBSCHYDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.59

1.78

-0.19

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.05

0.59

-0.54

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.29

Sharpe Ratio (All Time)

Calculated using the full available price history

0.26

0.65

-0.40

Drawdowns

IBB vs. SCHY - Drawdown Comparison

The maximum IBB drawdown since its inception was -62.85%, which is greater than SCHY's maximum drawdown of -24.04%. Use the drawdown chart below to compare losses from any high point for IBB and SCHY.


Loading charts...

Drawdown Indicators


IBBSCHYDifference

Max Drawdown

Largest peak-to-trough decline

-62.85%

-24.04%

-38.81%

Max Drawdown (1Y)

Largest decline over 1 year

-9.63%

-9.11%

-0.52%

Max Drawdown (3Y)

Largest decline over 3 years

-24.85%

-12.16%

-12.69%

Max Drawdown (5Y)

Largest decline over 5 years

-39.82%

-24.04%

-15.78%

Max Drawdown (10Y)

Largest decline over 10 years

-39.82%

Current Drawdown

Current decline from peak

-5.97%

-5.55%

-0.42%

Average Drawdown

Average peak-to-trough decline

-21.17%

-4.97%

-16.20%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.08%

2.90%

+0.18%

Volatility

IBB vs. SCHY - Volatility Comparison

iShares Nasdaq Biotechnology ETF (IBB) has a higher volatility of 6.87% compared to Schwab International Dividend Equity ETF (SCHY) at 2.83%. This indicates that IBB's price experiences larger fluctuations and is considered to be riskier than SCHY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


IBBSCHYDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.87%

2.83%

+4.04%

Volatility (6M)

Calculated over the trailing 6-month period

15.57%

9.86%

+5.71%

Volatility (1Y)

Calculated over the trailing 1-year period

20.10%

11.96%

+8.14%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

21.97%

13.26%

+8.71%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

23.22%

13.23%

+9.99%

IBB vs. SCHY - Expense Ratio Comparison

IBB has a 0.47% expense ratio, which is higher than SCHY's 0.08% expense ratio.


Dividends

IBB vs. SCHY - Dividend Comparison

IBB's dividend yield for the trailing twelve months is around 0.23%, less than SCHY's 3.45% yield.


PositionTTM20252024202320222021202020192018201720162015
IBB
iShares Nasdaq Biotechnology ETF
0.23%0.23%0.29%0.26%0.31%0.21%0.21%0.33%0.20%0.30%0.19%0.03%
SCHY
Schwab International Dividend Equity ETF
3.45%3.55%4.64%3.97%3.67%1.73%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


IBB and SCHY have a correlation of 0.53, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

IBB has higher volatility (6.87%) compared to SCHY (2.83%). In terms of maximum drawdown, IBB dropped -62.85% vs SCHY's -24.04%.

On 5-year performance, SCHY leads with 7.76% vs 1.05% for IBB. On fees, SCHY is cheaper at 0.08% per year. On volatility, SCHY has been the lower-risk option at 2.83%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 5-year period, SCHY has performed better with a 7.76% return vs 1.05%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

SCHY is cheaper with a 0.08% expense ratio, compared with 0.47% for IBB.

SCHY has the higher dividend yield at 3.45%, compared with 0.23% for IBB.

IBB is categorized as Health & Biotech Equities, while SCHY is Dividend. IBB tracks NASDAQ Biotechnology Index, while SCHY tracks Dow Jones International Dividend 100 Index. They also come from different issuers: iShares and Charles Schwab. Their fees differ too: 0.47% for IBB and 0.08% for SCHY.

SCHY currently has the higher Sharpe Ratio (1.78 vs 1.59), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for IBB and SCHY

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer